Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Neoplasms 18Breast Neoplasms 15Prostatic Neoplasms 14Colorectal Neoplasms 13Lung Neoplasms 11Hematopoietic and Lymphatic System Neoplasm 11Ovarian Neoplasms 5Hematologic Neoplasms 5Multiple Myeloma 4Malignant Solid Neoplasm 4Depression 4Uterine Cervical Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Lymphoma 3Hematopoietic and Lymphoid System Neoplasm 3Anxiety Disorders 3Anatomic Stage I Breast Cancer AJCC v8 3Advanced Malignant Solid Neoplasm 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Cancer, Papillary 2Motor Activity 2Melanoma 2Malignant Female Reproductive System Neoplasm 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Chemotherapy-Induced Peripheral Neuropathy × Interviews as Topic × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡